GenSci Invites You to Meet Us at Pharmedi Vietnam 2024

Sep. 03, 2024, Shanghai - GenSci announced its participation in the upcoming 2024 Pharmed & Healthcare Vietnam exhibition, held on September 11-14th, 2024, at Saigon Exhibition & Convention Center, Ho Chi Minh City, Vietnam. Our latest innovations and flagship products will be shared at the B12 Booth from September 11 to 13.

During the exhibition, we will showcase the products in the fields of pediatric and women’s health and dermatologic health including Jintropin^® Recombinant Human Growth Hormone Injection, Sai Xin^® progesterone injection (II) and Human Granulocyte/Macrophage Colony-stimulating Factor Hydro-gel for Topical Application. Our pipeline product, Genakumab for Injection, also will be accessible to all professionals and partners attending the event. 

As a pioneering genetic engineering pharmaceutical company, GenSci is renowned for its contributions to pediatric and women’s health. With nearly three decades, GenSci has accumulated rich experience in biopharmaceuticals and innovative drug development. Currently, GenSci boasts a global footprint in key regions such as the USA, Europe, and Singapore. Notably, in the Southeast Asian market, we have formulated sophisticated strategies to deliver premier healthcare services tailored to the needs of patients in that region. 

Pharmed & Healthcare Vietnam exhibition is the largest and most influential professional regular exhibition in the healthcare industry in Vietnam and one of the well-known professional medical exhibitions in Southeast Asia. GenSci eagerly anticipates the opportunity to share knowledge with esteemed scientists and experts globally at this exhibition.